Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic

The aftermath of the initial phase of the COVID-19 pandemic may contribute to the widening of disparities in access to colorectal cancer (CRC) screening due to differential disruptions to CRC screening. This comparative microsimulation analysis uses two CISNET CRC models to simulate the impact of ongoing screening disruptions induced by the COVID-19 pandemic on long-term CRC outcomes. We evaluate three channels through which screening was disrupted: delays in screening, regimen switching, and screening discontinuation. The impact of these disruptions on long-term colorectal cancer (CRC) outcomes was measured by the number of Life-years lost due to CRC screening disruptions compared to a scenario without any disruptions. While short-term delays in screening of 3-18 months are predicted to result in minor life-years loss, discontinuing screening could result in much more significant reductions in the expected benefits of screening. These results demonstrate that unequal recovery of screening following the pandemic can widen disparities in colorectal cancer outcomes and emphasize the importance of ensuring equitable recovery to screening following the pandemic.


Introduction 26
The novel SARS-Cov-2 (COVID-19) pandemic has resulted in major health consequences 27 across the globe. In addition to the over 1 million COVID-19 deaths in the United States, 1 28 the pandemic has also contributed to steep declines in cancer screening, most notably in 29 the early phases of the pandemic due to government-mandated shutdowns of non- The objective of this study is to estimate the impact of ongoing screening and 56 treatment disruptions induced by the COVID-19 pandemic on long-term CRC outcomes. We 57 examine twenty-five scenarios that reflect different levels of pre-pandemic adherence to 58 colonoscopy and FIT screening to assess how unequal recovery in screening may 59 contribute to widening disparities in CRC lifetime outcomes.

Cohorts 78
We simulated eight pre-pandemic population cohorts that represent average-risk 79 individuals in the United States, defined by both cohort members' age in April 2020 and 80 their pre-pandemic screening regimens: i) Unscreened 50-year-olds (U50), ii) Unscreened 81 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 26, 2022. ; https://doi.org/10.1101/2022.12.23.22283887 doi: medRxiv preprint 60-year-olds (U60), iii) Colonoscopy screening-adherent 60-year-olds (C60, who received 82 their first screening colonoscopy at age 50 but have not yet had a colonoscopy at age 60), 83 iv) FIT screening-adherent 60-year-olds (F60, who performed annual FIT  analysis -that is, the effect of short-term regimen switching is expected to be lower than 139 the effect of permanent regimen switching.

142
We also simulate scenarios where screening is completely discontinued after the 143 pandemic onset as the most consequential boundary case scenario. While only a small 144 (unknown) proportion of individuals will discontinue screening after the pandemic, this  Each of the scenarios simulated in this study results from the combination of a pre-150 pandemic population cohort, a no-disruption screening scenario that serves as a 151 counterfactual, and one or more screening disruptions (i.e., switching to FIT screening 152 occurred in tandem with short-term delays).   Table 1.

172
The key outcome estimated in this study is the expected number of LY lost (LYL)

179
Following previous analyses, we present all outcomes as LY per 1,000 individuals or life 180 days per person. We compute each of those outcomes separately for each model and report 181 the range of outcomes observed across both models.

Results 184
Loss of life due to screening disruptions was the largest for cohorts with severe disruptions  Table 3). Other disruption scenarios 190 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

216
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

224
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 26, 2022.
70-year-olds lose fewer life-years due to screening disruptions but can still be 225 affected by the pandemic as they are at greater risk for CRC than younger age groups.

280
These results highlight the potential implications of disruptions to preventative 281 care due to loss of insurance following the pandemic. According to data from the Bureau 282 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.    regimen switching in the population after the pandemic, which will not be available for 308 many years. Instead of pursuing a population-level study, we conditioned our estimates 309 on a discrete set of pre-specified disruption scenarios. This approach makes our study 310 feasible but prevents us from making population-level predictions.

311
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

354
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

452
Results are ordered from highest to lowest reduction in benefit induced by the pandemic 453 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

457
Results are ordered from highest to lowest reduction in benefit induced by the pandemic.

458
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.     . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

514
We assume that individuals with an adenoma detected undergo colonoscopic surveillance 515 according to the Multi-Society Task Force (MSTF) guidelines. These guidelines provide 516 intervals for surveillance based on baseline findings and findings at the first surveillance 517 colonoscopy. We assume the intervals provided can be more generally expressed as the 518 intervals based on the most recent colonoscopy ("first most recent colonoscopy") and the 519 colonoscopy prior to that ("second most-recent colonoscopy"). In situations where the MSTF 520 provided a range rather than a single interval, we assumed that the shortest interval would be 521 used in routine practice. The resulting intervals are shown in Supplementary Table 3.

523
We assume that persons in whom adenoma(s) have been detected remain on 524 surveillance until age 85, provided that no adenomas are detected at the last surveillance 525 colonoscopy. If adenomas are detected, then surveillance continues according to the clinical 526 findings at the last colonoscopy until the person has a colonoscopy with no adenomas detected.

527
For example, if a person has a surveillance colonoscopy at age 83 and no adenomas are 528 detected at this exam or the exam before this one, they would be recommended to have their 529 next surveillance at age 93. Age 93 is after the surveillance stopping age of 85 and the exam 530 prior to age 85 was negative, so they will not have any more surveillance colonoscopies after 531 age 83. However, if the exam at age 83 instead detected 1-2 small adenomas, they would come 532 back for their surveillance colonoscopy at age 90, because adenomas were detected at the exam 533 at age 83. As noted in the section on adherence above, in the primary analyses, we assume 534 persons with adenoma findings are perfectly adherent with the surveillance colonoscopy 535 schedules shown in Supplementary Table 3. 536 537 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint 541 ‡ The Multi-Society Task Force provides a range for some intervals (e.g., the interval for 3-4 adenomas <10 mm is 3-5 years).

542
In such cases, we selected the shortest intervals provided.
543 § A person whose first screening or diagnostic colonoscopy is normal does not enter surveillance but instead resumes 544 screening with the original modality 10 years after the normal colonoscopy. The exception to the 10-year waiting period 545 is when the first colonoscopy is a screening colonoscopy with an x-year interval, where x >10. In that case, the next 546 colonoscopy is in x years.

547
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 26, 2022. ; https://doi.org/10.1101/2022.12.23.22283887 doi: medRxiv preprint